ArticleCancer2023

Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity.

Max J Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.